Delfim Duarte, MD PhD
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal
Cell competition as a mechanism to eliminate minimal residual disease in acute myeloid leukemia
University of Wisconsin
Improving Specific Targeting of Neuroblastoma Tumors through Bispecific SNIPER Antibody to Reduce Off-Target Toxicities
The University of Texas Health Science Center
The Epitranscriptomic Pathway is a Therapeutic Vulnerability in p53-mutant Osteosarcoma
University of Texas M.D. Anderson Cancer Center
Assessment of a cancer preventive agent for Wilms tumor
Institute for Biomedical Research August Pi i Sunyer-Barcelona, Spain
Opsoclonus myoclonus syndrome: a novel approach to antigen identification and disease modeling
Grant Funded in Partnership with The Viswanatha Family + Friends
Baylor College of Medicine
T cells expressing a next-generation glypican-3-specific CAR incorporating IL-7 receptor signaling to cure pediatric liver cancers
Cincinnati Children’s Hospital Medical Center
Identification of cellular diversity and tumor-initiating cells driving NF-to-MPNST and drug resistance by single-cell multiomics for targeted therapy
Supported in part by Hanna's Hoops 4 Healing
Baylor College of Medicine
Predicting Atovaquone-Induced Apoptosis in Pediatric AML
Children’s Hospital Boston
Targeting leukemia stem cells in infant B-lymphoblastic leukemia
This grant is funded by Change a Life Foundation
Children's Hospital Los Angeles
Cancer Stem Cells in Wilms Tumor: Can the Self-Renewal State Be Pushed to Nephrogenesis?
University of Michigan
The sirtuin SIRT5 as a novel therapeutic target for Ewing's Sarcoma
This grant is funded by Peloton Magazine
Johns Hopkins University - School of Medicine
Investigating novel glutamine antagonists as a therapeutic strategy for malignant peripheral nerve sheath tumors
University of California San Francisco
Drugging the Aurora Kinase A Interactome in Neuroblastoma
University of California Los Angeles
Utilizing Pluripotent Stem Cells to Evaluate the Role KIT and KRAS Play in Germ Cell Development and Tumorigenesis
John Hopkins Universtiy
Identification and targeting of circulating Ewing sarcoma stem cells
University of Vermont
Critical Contributions of CRM1 to Pediatric Leukemogenesis.
Texas Children's Hospital, Baylor College of Medicine
Glypican-3 specific T-cells for the adoptive immunotherapy of pediatric liver cancers
Massachusetts General Hospital
Discovery of Epigenetic Factors Essential for T Cell Leukemia